BrightSpring Health Services (BTSG) Cost of Revenue (2023 - 2026)

BrightSpring Health Services has reported Cost of Revenue for 4 years, with the latest figure at $260.9 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 23.34% year-over-year to $260.9 million; the trailing twelve-month figure through Mar 2026 stood at $934.7 million (up 13.62% YoY), and the FY2025 full-year result was $885.4 million, up 11.05% from the prior year.
• Cost of Revenue for Q1 2026 stood at $260.9 million, up from $236.6 million in the prior quarter.
• The five-year high for Cost of Revenue was $1.9 billion in Q3 2023, with the low at -$4.7 billion in Q4 2023.
• Historically, Cost of Revenue has averaged $103.7 million across 4 years, with a median of $216.4 million in 2025.
• The largest YoY upside for Cost of Revenue was 104.62% in 2024 against a maximum downside of 89.41% in 2024.
• BrightSpring Health Services' Cost of Revenue stood at -$4.7 billion in 2023, then surged by 104.62% to $215.8 million in 2024, then grew by 9.64% to $236.6 million in 2025, then advanced by 10.29% to $260.9 million in 2026.
• The last three Cost of Revenue figures came in at $260.9 million (Q1 2026), $236.6 million (Q4 2025), and $220.8 million (Q3 2025), per Business Quant data.